Haematologica (Nov 2018)

Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia

  • Farhad Ravandi,
  • Ellen K. Ritchie,
  • Hamid Sayar,
  • Jeffrey E. Lancet,
  • Michael D. Craig,
  • Norbert Vey,
  • Stephen A. Strickland,
  • Gary J. Schiller,
  • Elias Jabbour,
  • Arnaud Pigneux,
  • Heinz-August Horst,
  • Christian Récher,
  • Virginia M. Klimek,
  • Jorge E. Cortes,
  • Angelo-Michele Carella,
  • Miklos Egyed,
  • Utz Krug,
  • Judith A. Fox,
  • Adam R. Craig,
  • Renee Ward,
  • Jennifer A. Smith,
  • Gary Acton,
  • Hagop M. Kantarjian,
  • Robert K. Stuart

DOI
https://doi.org/10.3324/haematol.2018.191361
Journal volume & issue
Vol. 103, no. 11

Abstract

Read online

No abstracts available.